Company Filing History:
Years Active: 2002
Title: Julie Lindemann: Innovator in Cancer Treatment
Introduction
Julie Lindemann is a notable inventor based in El Cerrito, California. She has made significant contributions to the field of cancer treatment through her innovative research and patents. Her work focuses on the use of specific metabolites derived from alpha-linolenic acid to combat cancer in mammals.
Latest Patents
Julie Lindemann holds a patent for the "Use of α-linolenic acid metabolites for treatment or prevention of cancer." This patent outlines a method for treating or preventing cancer in mammals by administering a cancer-inhibiting amount of metabolites from α-linolenic acid. Key metabolites mentioned in her patent include stearidonic acid, eicosatetraenoic acid, and docosapentaenoic acid, with a particular emphasis on stearidonic acid.
Career Highlights
Julie is associated with Monsanto Technology LLC, where she continues to advance her research in cancer treatment. Her dedication to innovation in this field has led to the development of effective methods for cancer prevention and treatment.
Collaborations
Julie has collaborated with notable colleagues such as Mark G Obukowicz and Ayman Kabakibi. Their combined expertise has contributed to the success of her research and the impact of her patent.
Conclusion
Julie Lindemann's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. Her contributions through her patent and collaborations highlight her commitment to improving treatment options for patients.